Cyteir Therapeutics Inc Headquarters
Looking for information about Cyteir Therapeutics Inc Headquarters? The links below have collected all the necessary data.
Cyteir’s Culture. With a pioneering spirit, putting patients first, we advance science passionately and collaboratively, in a fun learning environment. We value open, honest and transparent communication. We work diligently with respect for each other with a sense of urgency, integrity, accountability and purpose. Learn More.Estimated Reading Time: 1 min
https://craft.co/cyteir-therapeutics/locations
Cyteir Therapeutics headquarters and office locations. Cyteir Therapeutics is headquartered in Lexington, MA and has 1 office location across 1 country. View Company. Filter locations by country. United States;Location: 128 Spring St, Lexington
https://cyteir.com/contact
https://www.bloomberg.com/profile/company/1340516D:US
Cyteir Therapeutics, Inc. operates as a pharmaceutical company. The Company discovers, develops, and produces synthetic lethal therapies to treat cancer and autoimmune diseases.Leader: Kevin Mills, Dr Markus F Renschler
https://craft.co/cyteir-therapeutics
Jul 07, 2020 · Cyteir Therapeutics is engaged in developing medicines for the treatment of cancer and autoimmune diseases. The Company uses an integrated drug development platform that modulates the imbalance between DNA damage and repair for the therapeutic effect to deliver a pipeline of small molecule therapeutics with a range of potential disease state applications.Employees: 30
https://www.crunchbase.com/organization/cyteir-therapeutics
Legal Name Cyteir Therapeutics, Inc. Stock Symbol NASDAQ:CYT. Company Type For Profit. Contact Email [email protected]. Phone Number 312-953-3651. Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA ...Founded: 2012
https://www.zoominfo.com/c/cyteir-therapeutics-inc/357397398
Cyteir Therapeutics Announces Closing of Initial Public Offering LEXINGTON, Mass.--(BUSINESS WIRE)--Cyteir Therapeutics, Inc. (“Cyteir”) (Nasdaq: CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, today announced the closing of its initial public offering of 7,400,000 shares of its common stock at an initial public ...Employees: 31
Have you found Cyteir Therapeutics Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|